GlassScriptPhysician profile
Craig Rodney Mccready
NPI 1093004616
$14,199.56
in general payments reported to CMS, 2019-2025
22 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $21.92 · 2021: $8,596 · 2022: $1,768 · 2023: $3,483 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $639.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,762.28 | 2021-2023 | Davinci Xi |
| Integra Lifesciences Corporation | $341.82 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $300.62 | 2021-2023 | Endoflip |
| Davol INC. | $147.55 | 2021-2023 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $111.38 | 2019 | |
| Abbvie INC. | $83.39 | 2023 | |
| Tela Bio, INC. | $57.52 | 2022 | |
| Innocoll Pharmaceuticals Limited | $54.44 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $42.20 | 2021 | |
| Aroa Biosurgery Incorporated | $40.31 | 2025 | |
| Polynovo North America LLC | $31.44 | 2021 | |
| Baxter Healthcare | $30.36 | 2021-2022 | |
| Ethicon US, LLC | $26.54 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $24.06 | 2019 | |
| Biom'Up Sa | $23.04 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $22.30 | 2025 | Fibryga |
| Biom'Up France Sas | $21.92 | 2020 | |
| Allergan, INC. | $20.34 | 2022 | |
| Dilon Technologies, INC. | $15.42 | 2023 | Hemoblast Bellows |
| Acera Surgical, INC. | $15.38 | 2019 | |
| Reprise Biomedical, INC. | $13.73 | 2021 | |
| La Jolla Pharmaceutical Company | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Mccready listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.